Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

43.25
+1.854.47%
Post-market: 43.250.00000.00%16:04 EDT
Volume:1.26M
Turnover:55.02M
Market Cap:1.82B
PE:-15.91
High:45.48
Open:43.26
Low:42.43
Close:41.40
Loading ...
Aug 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 23, 2024

Major Issues Report

Form 8-K - Current report
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2024

Major Issues Report

Form 8-K - Current report